Biosimilars for the management of inflammatory bowel diseases: Economic considerations

L. Gulacsi, M. Pentek, F. Rencz, V. Brodszky, P. Baji, Z. Vegh, K.B. Gecse, S. Danese, L. Peyrin-Biroulet, P.L. Lakatos

Research output: Contribution to journalArticle (Academic Journal)peer-review

29 Citations (Scopus)

Cite this